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ABSTRACT 17 
Diabetes is typically diagnosed in cats once clinical signs are evident. Diagnostic criteria for 18 
prediabetes in cats have not been defined. The objective of the study was to establish 19 
methodology and cutpoints for fasting and 2-h blood glucose concentrations in healthy client-20 
owned senior cats (> 8 yrs) using ear/ paw samples and a portable glucose meter calibrated 21 
for feline blood. Of the 78 cats, 27 were ideal (body condition score (BCS) 4 or 5 out of 9), 22 
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31 overweight (BCS 6 or 7) and 20 obese (BCS 8 or 9); 19 were Burmese and 59 non-23 
Burmese. Following an 18 - 24 h fast and an ear/paw blood glucose measurement using a 24 
portable glucose meter, glucose (0.5 g/kg bodyweight) was administered  IV  and blood 25 
glucose measured at 2 min and 2 h. Cutpoints for fasting and 2-h glucose concentrations were 26 
defined as the upper limits of 95% reference intervals using cats with BCS 4 or 5. The upper 27 
cutpoint for fasting glucose was 6.5 mmol/L. Of the overweight and obese cats, one (BCS 7) 28 
was above this cutpoint indicating evidence of impaired fasting glucose. The cutpoint for 2-h 29 
glucose was 9.8 mmol/L. A total of 7 cats (4 with BCS 8 or 9 including 1 Burmese; 3 with 30 
BCS 6 or 7, non-Burmese) were above this cutpoint and thus had evidence of impaired 31 
glucose tolerance. In conclusion, the methodology and cutpoints for diagnosis of prediabetes 32 
are defined for use in healthy cats 8 yrs and older with a range of body condition scores.  33 
 34 
1. Introduction 35 
In cats, 0.2% to 1% [1-3] are reported to be diabetic compared to 4 [4] to 10% [4,5] of 36 
humans. Humans with blood glucose concentrations above normal but below diabetic for 37 
fasting or at 2-h in a glucose tolerance test are classed as having impaired fasting glucose or 38 
impaired glucose tolerance respectively. They are considered prediabetic and develop 39 
diabetes at a rate of 5 - 10% per yr [6,7].  It is estimated that over 50% of humans in the USA 40 
with diabetes are undiagnosed [8], and the number with undiagnosed prediabetes is 3 to 4 41 
times greater than with undiagnosed diabetes [8]. There are no corresponding data for cats in 42 
the veterinary literature. As in humans, there is a genetic predisposition for feline diabetes. 43 
Burmese cats from the United Kingdom and Oceania are approximately 4 times more likely 44 
to develop diabetes than other breed [9], with one in 50 affected [2]. 45 
Diagnostic criteria for subclinical and pre-diabetes in cats have not been defined, and cats are 46 
not typically diagnosed until clinical diabetes is evident. In obese cats, mild fasting or 47 
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postprandial hyperglycemia is reported to be the only early sign of diabetes, prior to onset of 48 
classical signs of diabetes such as polyuria [10]. Reported upper limits for normal fasting 49 
blood glucose in cats vary from 6.1 mmol/L [11] to 9 mmol/L [12-14]; this variability is due 50 
at least in part to a lack of standardization of the test protocol.  51 
Intravenous (IV) glucose tolerance tests are used to assess glucose tolerance in cats [15]. The 52 
‘gold standard’ test requires multiple samples and interpretation can be difficult because of 53 
the complex calculations required to generate the necessary statistics such as glucose half- 54 
life, glucose clearance time and area under the curve. Veterinarians need screening tests for 55 
impaired fasting glucose and impaired glucose tolerance that are inexpensive, non-invasive, 56 
and easy to perform and interpret in a clinical setting. A standardized IV glucose tolerance 57 
test would need a standardised glucose dose rate, fasting period, sampling times, and an 58 
established reference range applicable to all cats, lean, overweight and obese. 59 
Numerous portable blood glucose meters calibrated for human blood are used for glucose 60 
monitoring in cats [16-18]. Although precise, they are less accurate, typically measuring 0.5 61 
to 2.2 mmol/L lower  than a serum chemistry analyser [19]. A meter validated for feline 62 
blood, requiring a 0.3 uL blood sample is now commercially available [20], facilitating 63 
successful blood sampling from the ear or foot pad and more accurate measurements. A 64 
simplified protocol for IV glucose tolerance testing in cats using this glucose meter has been 65 
reported using a glucose dose of 1g/kg [7], but from a practitioner’s perspective, the volume 66 
to be infused can be problematic. A glucose dose of 0.5 g/kg is typically used in cats for 67 
assessing glucose tolerance whereas 1 g/kg is used for assessing maximal insulin secretory 68 
capacity. 69 
Administering an IV glucose dose to overweight and obese cats based on bodyweight 70 
spuriously affects some measures of glucose tolerance [21]. This is presumed to occur 71 
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because blood volume does not increase linearly with the increase in body weight due to 72 
obesity [22]. As a result, peak (2-min) glucose concentration is higher in obese cats, which 73 
subsequently increases 2-h glucose concentration when glucose is dosed on bodyweight [21]. 74 
This can be overcome by adjusting either the glucose dose or measured 2–h blood glucose 75 
concentration based on body condition score, so that one reference interval can be used for 76 
lean, overweight and obese cats. To the authors’ knowledge, these adjustments have not been 77 
applied to cats in the age group at risk of diabetes (≥ 8 yrs). 78 
The aims of this study were to establish methodology and cutpoints for fasting and 2–h blood 79 
glucose concentration in healthy client-owned, senior cats of varying body condition using 80 
ear/ paw samples and a portable glucose meter calibrated for feline blood, to compare these 81 
between Burmese and non-Burmese cats, to apply adjustment equations to 2–h blood glucose 82 
concentrations in overweight and obese cats. 83 
 84 
2. Materials and Method 85 
1.1. Study overview: 86 
The protocol for these studies and the care and handling of these animals were approved by 87 
the Animal Experimentation Ethics Committee of the University of Queensland approval 88 
number SVS/040/10/NC/ABBOTT. In 78 client-owned cats, fasting blood glucose was 89 
measured from a paw or ear sample using a portable glucose meter then an IV glucose 90 
tolerance test performed using a glucose dose of 0.5g/kg. This was repeated in 8 of these cats 91 
23 to 57 d later to determine variability over time. An IV glucose tolerance test using the 92 
same protocol but a glucose dose rate of 1g/kg was also subsequently performed in 11 of the 93 
78 cats.  94 
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1.2. Animals:  95 
Clinically healthy client-owned cats  ≥ 8 yrs (n = 90) were recruited though veterinary clinics, 96 
advertisements and radio interviews between May 2011 and November 2012. Cats were 97 
tested at the University of Queensland Small Animal Clinic and a private specialist cat clinic. 98 
All cats included in the study appeared clinically healthy during examination. The cats were 99 
not on any medications except routine flea and worming control. Exclusions were based on 100 
haematological and biochemical panels, body condition score (BCS) of ≤ 3 out of a 9 point 101 
scale [23] and behaviour of the cats. Exclusions (n = 12) were for stress/ aggressive 102 
behaviour (n = 3), suspected pancreatitis based on increased fPLI of > 3.5 ug/L in line with 103 
the general interpretive guidelines of our reference laboratory (n = 2), hyperthyroidism (n = 104 
3), ongoing health issues (n = 2), pancreatic cancer (n = 1) and BCS ≤ 3 out of 9 (n = 1). 105 
Remaining cats (n = 78) were classified as non-Burmese (n = 59) or Burmese (n = 19). Body 106 
condition scores of the cats (out of 9) [23] included in the study were all assessed by one 107 
person (MRJ), and were 4 (8 cats), 5 (19 cats), 6 (14 cats), 7 (17 cats), 8 (14 cats) and 9 (6 108 
cats). Data was collected on diets of the study cats and consisted of a variety of supermarket, 109 
premium and home cooked dry and tinned food. 110 
1.3. Protocol: 111 
Cats were admitted to the hospital the d before the glucose tolerance tests and all cats stayed 112 
overnight. On admission, a 5-mL venous blood sample was collected for a routine health 113 
screen performed by a commercial veterinary diagnostic laboratory (Idexx Laboratories, 114 
Brisbane Australia). The following morning, after food was withheld for 18 to 24 h, a jugular 115 
venous blood sample (4 mL) was collected for hormone assays and then a 22 - gauge catheter 116 
(Surflo 22G x1” intravenous catheter, Terumo Europe, Belgium) was placed in the cephalic 117 
vein and flushed (2 mL 0.9% sodium chloride (Baxter)). To allow for resolution of stress 118 
hyperglycemia, fasting blood glucose was measured 3 h after catheter placement [24]. A 119 
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portable glucose meter calibrated for feline blood (Abbott Alpha Trak©) was used and the 120 
sample obtained from the paw or ear. Glucose (undiluted 50% glucose injection BP; Astra 121 
Pharmaceutical) (0.5g/kg) was then administered IV over 30 sec via the catheter. A timer was 122 
started halfway through the infusion and blood samples were taken at 2 min, 2 h and then 123 
hourly until glucose returned to below our laboratory’s upper limit of normal fasting glucose 124 
concentration of 6.5 mmol/L [25]. On completion, the catheter was removed, cats were fed 125 
and discharged. 126 
 127 
Blood samples from syringes from 3 cats were analysed 20 times with 2 different portable 128 
glucose meters of the same brand within 1 h of collection to assess intra and inter-meter 129 
variability. The interassay CV for the glucose meter was 2 % and the intra-assay 3.3 %. To 130 
determine repeatability, fasting blood glucose assessments and glucose tolerance tests were 131 
repeated in 8 cats 23 to 57 d after their first admission (median 42 days). To compare the 132 
previously-derived adjustment equations with those derived from this population of cats, a 133 
glucose tolerance test using the same protocol but a glucose dose rate of 1g/kg was also 134 
performed in 11 of the 78 cats (BCS 4 n = 3; 5 n = 3; 7 n = 4; 8 n = 1) 38 to 365 d later 135 
(median 60 d), depending on client availability, after their first glucose tolerance test. 136 
 137 
1.4. Statistical analyses: 138 
Reference intervals for fasting and 2-h glucose concentration were calculated using published 139 
method used in humans, whereby data are transformed as necessary and outliers identified 140 
and excluded from analysis [26]. This methodology results on average in a 10 % narrower 141 
reference interval than if outlier detection was not used [27]. Data were entered into a 142 
spreadheet (Microsoft Excel, Reference Interval Draft Version, Copyright 2005, University 143 
of Cincinnati), transformed to approximate a normal distribution using the Box-Cox 144 
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transformation, and outliers excluded from subsequent calculations. Diagnositc cutpoints 145 
were defined as the upper limits of the 95% reference intervals. Associated 90% confidence 146 
intervals (CI) for the upper limits of the reference intervals were estimated using 147 
bootstrapping with 1000 replications. Based on a priori knowledge that some overweight and 148 
obese cats have abnormal glucose tolerance [15], only lean cats (BCS of 4 or 5) were used for 149 
estimating fasting and 2–h reference intervals. Data from Burmese were pooled with non-150 
Burmese to determine reference intervals for fasting and 2-h glucose concentrations as the 151 
median glucose concentrations and interquartile ranges were similar (median fasting Burmese 152 
and non-Burmese 4.6 and 4.7 mmol/L, respectively, and 0.7 and 1.1 mmol/L respectively; 153 
median 2-h Burmese and non-Burmese 6.2 and 5.7 mmol/L respectively, and interquartile 154 
range 2.6 and 3.1 mmol/L, respectively. 155 
Repeatability was established using repeatability coefficients calculated using specialized 156 
software (the Pairs etc module (version 3.57) of the WinPepi software (version 11.62; 157 
www.brixtonhealth.com)). 158 
 Repeatability coefficients were calculated:  159 
based on the within-cat variance. Approximate 95% CIs were obtained by substituting 160 
confidence limits for the within- cat variance, estimated by the method described by Zar [28] 161 
(formula 7.16). 162 
 163 
Associations between breed (Burmese or non-Burmese) and each of 2-min and 2-h glucose 164 
concentrations were assessed using linear regression with body condition score, age (both 165 
fitted as continuous variables) and sex (fitted as covariates). Associations between body 166 
condition score and 2-min glucose concentration, 2-min and 2-h glucose concentration and 167 
fasting and 2-h glucose concentrations were each assessed using univariable linear regression. 168 
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Homoscedasticity of  residuals were assessed using plots of residual versus fitted values. The 169 
effects of glucose dose on 2-h glucose concentration were also assessed using linear 170 
regression, with cat-time as the unit of analysis, with cat fitted as a random effect; maximum 171 
likelihood estimation was used. Interactions between dose and each of breed (Burmese or 172 
non-Burmese) and body condition score (fitted as a continuous variable) were also assessed. 173 
Regression analyses were performed using a commercial software program (Stata (version 174 
12, StataCorp, College Station, Texas, USA)) .  175 
1.5. Adjustments of measured 2-h glucose: 176 
We used two  previously developed algorithms (Reeve-Johnson et al, unpublished data), to 177 
compensate for the spurious effect on 2-h glucose concentration that arises from dosing on a 178 
bodyweight basis (rather than using total blood volume),  as previously demonstrated in 179 
obese dogs [22]. Using one algorithm, observed 2-h glucose concentration was adjusted 180 
downward by 0.1 mmol/L for every unit of BCS above 5. Using the other algorithm, the 181 
difference between the observed 2-min blood glucose concentration and the mean 2-min 182 
blood glucose concentration of lean cats (17.5 mmol/L) was calculated, and multiplied by 183 
0.09. The measured 2-h blood glucose concentrations were then adjusted downwards by 184 
subtracting the calculated product; this was done for all cats with values above the upper 185 
cutpoint.  186 
 187 
2. Results 188 
2.1. Fasting blood glucose concentrations 189 
The upper cutpoint for fasting blood glucose concentration in cats with BCS 4 and 5 (n = 27) 190 
was 6.5 mmol/L based on the upper limit of the 95% reference interval (Table 1). When the 191 
statistical power was increased by including all 78 study cats (BCS varied from 4 to 9), the 192 
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upper cutpoint was 6.3 mmol/L and the 90% CI 6.0 to 6.5 mmol/L. Only 1 of the 51 cats 193 
(2%) with BCS 6 to 9 was classed as having impaired fasting glucose (> 6.5 mmol/L) based 194 
on this cutpoint (BCS 7; non-Burmese), as well as one of the lean cats (BCS 5; non-195 
Burmese). The lower limit of the 95% reference interval for cats with BCS 4 and 5 was 3.9 196 
mmol/L (90% CI 3.6 to 4.2 mmol/L), and when all 78 cats were included, was 3.4 mmol/L 197 
(90% CI 3.2 to 3.5 mmol/L).   198 
  199 
When 8 lean cats were retested 23 to 57 d later, the repeatability coefficient for fasting blood 200 
glucose concentration was 1.1 mmol/L (95% CI  0.7 to 2.2 mmol/L) when data from 7 of the 201 
8 cats were used. One cat had an initial value of 4.6 mmol/L, and a value of 12.3 mmol/L 202 
after a further 43 d. At the first and second tests, fasting blood glucose concentrations for the 203 
other 7 cats ranged from 3.6 to 5.6 mmol/L and 4.1 to 5.7 mmol/L, respectively. When this 204 
cat was included in the data, the repeatability coefficient was 5.4 mmol/L (95% CI  3.7 to 205 
10.4 mmol/L). As the 95% CI for these repeatability coefficients was wide, this estimate 206 
should be interpreted with caution. The second value for this latter cat was inconsistent with 207 
fasting concentrations in healthy cats and may have been the result of stress hyperglycemia or 208 
laboratory error such as a bubble in the blood sample. These results indicate that when cats 209 
are tested twice 23 to 57 d apart, glucose concentrations differ within cats by up to about 1.1 210 
mmol/L for most cats.  211 
2.2. 2-h blood glucose concentrations 212 
 213 
The cutpoint for 2-h blood glucose concentration in an IV glucose tolerance test using 0.5 214 
g/kg glucose estimated from cats with BCS 4 or 5  (n = 27) was 9.8 mmol/L. This was the 215 
upper limit of the 95% reference interval (90% CI 8.5 to 10.7 mmol/L) (Table 1). The 216 
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repeatability coefficient for 2-h blood glucose concentration was 3.8 mmol/L (95% CI 2.6 to 217 
7.2 mmol/L). 218 
2.3. Adjustment for effect of BCS on interpretation of glucose tolerance test results  219 
The measured 2-h blood glucose concentration for cats in the present study was adjusted in 220 
overweight and obese cats (BCS > 5) using 2 previously established algorithms (Reeve-221 
Johnson et al, unpublished data), and the adjusted values compared to the upper cutpoints 222 
established in the present study. A total of 7 cats had 2-h glucose concentrations above the 223 
diagnostic cutpoint reported above of 9.8 mmol/L (4 obese (BCS 8 or 9), 3 overweight (BCS 224 
6 or 7); 5 domestic, 1 Burmese and 1 British Blue). Adjusted 2-h blood glucose 225 
concentrations from both algorithms for these 7 cats were all above the upper limit of the 226 
reference range, and thus all were considered to be glucose intolerant (data not shown).  227 
 228 
2.4. Effect of breed on fasting and 2-h blood glucose concentration 229 
Although Burmese cats are overrepresented amongst diabetic cats, after adjusting for BCS, 230 
sex and age, Burmese cats (n = 19) did not have significantly differing fasting and 2-h 231 
glucose concentrations compared to non-Burmese (n = 59) cats. After adjusting for BCS, sex 232 
and age, the estimated difference in mean 2-h blood glucose concentrations (Burmese minus 233 
non-Burmese) was -0.6 mmol/L (95% CI of difference -1.4 to 0.2; P = 0.140). After adjusting 234 
for BCS, sex and age, the estimated difference in mean 2-h blood glucose concentrations 235 
(Burmese minus non-Burmese) was 0.1 mmol/L (95% CI of difference -1.1 to 1.3; P = 236 
0.856). 237 
 238 
2.5. Associations between body condition score and 2-min glucose concentration, and 2-min 239 
glucose and 2-h glucose concentrations 240 
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There tended to be a positive association between 2-min glucose concentration and body 241 
condition score; for every 1 unit increase in body condition score, 2-min glucose 242 
concentration increased by 0.8 mmol/L  (95% CI -0.1 to -1.7mmol/L; P = 0.078). There was 243 
no significant association between 2-min and 2-h glucose concentrations (P = 0.396) but the 244 
point estimate was consistent with a positive relationship; for every 1 mmol/L increase in 2-245 
min glucose concentration, 2-h glucose concentration increased by 0.04 mmol/L (95% CI -246 
0.054 to -0.14). Although, these point estimates were not significantly associated, they were 247 
of similar magnitude to previously determined adjustments in another cohort of cats (Reeve-248 
Johnson et al, unpublished data). 249 
 250 
2.6. Effect of glucose dose rate on 2-h blood glucose concentrations 251 
We evaluated the effect of glucose dose (0.5 versus 1.0 g/kg bodyweight) on 2-h blood 252 
glucose concentrations in lean, overweight and obese cats (n = 11; BCS 4 n = 3; 5 n = 3; 7 n 253 
= 4; 8 n = 1). Increasing the dose rate from 0.5 g/kg to 1 g/kg increased 2-h glucose in non-254 
Burmese cats by an estimated 1.4 mmol/L (95% CI -0.1 to 2.8; P = 0.031). However in 255 
Burmese, relative to 0.5 g/kg, 1 g/kg had a much larger effect; 2-h glucose was 6.4 mmol/L 256 
higher than for the lower glucose dose (95% CI 4.6 to 8.1; P < 0.001; P for interaction 257 
0.001). Mean 2-h glucose concentration for Burmese was estimated to be 0.7 mmol/L lower 258 
than for non-Burmese (95% CI 1.2 lower to 2.6 higher; P =  0.483) at 0.5 g/kg but 5.6 259 
mmol/L higher (95% CI 3.7 to 7.5; P < 0.001) at 1 g/kg. No significant interaction was 260 
detected between dose and BCS (P for interaction 0.334). Increasing the dose rate from 0.5 261 
g/kg to 1 g/kg increased 2-h glucose by an estimated 2.2 mmol/L (95% CI -0.4 to 4.9; P = 262 
0.098) where BCS was 4, and by an estimated 4.5 mmol/L (95% CI 1.4 to 7.7; P = 0.005) 263 
where BCS was 8. 264 
 265 
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2.7. Associations between fasting glucose concentration and 2-h glucose concentrations 266 
We assessed whether there was an association between fasting glucose and glucose 267 
concentrations at 2-h in an IV glucose tolerance test, because cats with impaired fasting 268 
glucose might be expected to also have impaired glucose tolerance. For every unit increase in 269 
fasting glucose, 2-h glucose increased by 0.5 mmol/L  (P = 0.0064; 95% CI 0.2 to 0.9). Two 270 
cats of BCS 5 and 7 had high fasting glucose concentrations (>10 mmol/L) and this positive 271 
relationship between fasting and 2-h glucose was almost entirely due to these cats.  272 
 273 
3. Discussion 274 
In this study of cats 8 yrs or older, we established a standardized clinical protocol for 275 
diagnosing impaired fasting glucose and glucose tolerance using a portable glucose meter. 276 
The upper cutpoint for normal fasting glucose concentration was 6.5 mmol/L and for 2-h 277 
glucose concentration following a simplified IV glucose tolerance test (delivering 0.5 g/kg 278 
glucose dose) was 9.8 mmol/L. When applied to cats with a range of body condition scores, 279 
3% were classed as having impaired fasting glucose and 9% as glucose intolerant.  In 280 
contrast, 12 to 26 % [29] of human populations in USA, Europe and Australia have impaired 281 
fasting glucose and 7 to 28% are reported to be glucose intolerant [30,31].  However, 282 
reported rates of overweight and obesity are typically higher in these human populations (66-283 
75%) than are reported from feline studies (14 [32] - 63% [33]), although the rate in cats 284 
varies with the population studied, and how body condition was measured [33,34].  In the 285 
absence of more accurate data on the frequency of prediabetes in the feline population 8 yrs 286 
of age or older, it is unknown if more stringent cutpoints should be applied, for example, 90% 287 
reference intervals or lower. For fasting glucose, the 90% interval would result in an upper 288 
cutpoint of 6.2 mmol/L.  In humans, a link between microvascular disease such as 289 
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retinopathy and glucose concentrations [35] is well accepted. As this link has not been 290 
established in cats, we have chosen to use the 95% reference intervals.  291 
 292 
Currently, there is no accepted cutpoint between impaired fasting glucose and diabetes in cats 293 
and various values have been suggested ranging from 9.5 [36] to 16 mmol/L, with the latter 294 
approximately representing the renal threshold [14]. In humans, cutpoints were established in 295 
part based on the association with renal and microvascular complications [6]. There is an 296 
urgent need for these cutpoints to be established in cats, especially for fasting glucose, 297 
because this measurement is easily evaluated in clinical practice. The prevalence of 298 
undiagnosed diabetes in adults in a U.S. population was 2.8%, increasing to 5.8% by the age 299 
of 60 yrs [37]. It is unknown how many cats have undiagnosed diabetes. Until the cutpoint 300 
for diabetes is established, the authors suggest using 6.5 mmol/L as the upper cutpoint for 301 
impaired fasting glucose, and unstressed cats with glucose concentrations of >10 mmol/L that 302 
are confirmed with repeated measurements be considered diabetic [38]. 303 
 304 
Humans with impaired fasting glucose or impaired glucose tolerance are considered 305 
prediabetic [6,29,30], because they are at high risk of developing diabetes, with 5-10% of 306 
individuals progressing to diabetes per yr [35].   Evidence-based cutpoints are important for 307 
diagnosing pre-diabetes in at risk cats, such as obese and Burmese cats. Because cats with 308 
impaired fasting glucose or glucose intolerance are at increased risk of diabetes [7], 309 
prediabetic cats need to be identified, and management regimes implemented including 310 
weight loss and dietary intervention. 311 
 312 
3.1. Repeatability of fasting blood glucose concentrations 313 
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Repeatability coefficients describe repeatability from a clinical perspective, ie. if the same 314 
animal is sampled on different day, how much variation is likely between two results. This 315 
incorporates both the within lab precision plus the biological variation within the same 316 
animal. Repeatability studies showed that fasting glucose concentrations differed within cats 317 
over 3-7 weeks by approximately 1.0 mmol/L for most cats. The group size, the 318 
heterogeneity and the lack of acclimatization would have contributed to the relatively large 319 
variation. Diagnosis of impaired fasting glucose or impaired glucose tolerance in humans is 320 
based on the mean of two values measured no more than 3 months apart [6,30], and a similar 321 
recommendation would be prudent for cats. 322 
 323 
3.2. Reference values for 2-h blood glucose concentrations 324 
Our upper cutpoint for 2-h glucose concentration of 9.8 mmol/L was similar to 9.5 mmol/L 325 
established previously by Link et al [14] , but higher than 6.0 mmol/L calculated from 326 
Appleton’s raw data [39] (data not shown), and likely higher than estimated from Hoenig’s 327 
[15] lean cats (mean concentration estimated from graph was 5.6 mmol/L. The latter two 328 
studies used acclimatized research cats, and inserted jugular catheters under general 329 
anesthesia prior to obtaining blood samples, decreasing the probability for stress 330 
hyperglycaemia.  They also used automated analysers which delayed sample analysis and 331 
might have contributed to lower glucose concentrations. Link et al [14] used human portable 332 
glucose meters calibrated for whole blood which are biased to lower readings than meters 333 
calibrated for cat blood that provide plasma-equivalent measurements [20] . Appleton’s cats 334 
were much younger (1-5 yrs old) and there is some evidence glucose tolerance decreases with 335 
age in cats [40].  336 
 337 
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 Results from an IV glucose tolerance test is more sensitive (but slightly less specific) than 338 
fasting blood glucose for identifying people at high risk of diabetes [30]. Reflecting this 339 
higher test sensitivity, impaired glucose tolerance is more prevalent than impaired fasting 340 
glucose in human populations [30]. Similarly in our study, 9% of all cats and 20% of obese 341 
cats had impaired glucose tolerance, whereas only 3% of overweight cats (BCS 6–7), and no 342 
obese cats had impaired fasting glucose. We tested only cats  ≥ 8 yrs old and recruited a large 343 
proportion (65%) that were overweight or obese, because this age group and body condition 344 
are at greatest risk of developing diabetes. Also, glucose tolerance decreases with age and 345 
increasing body condition [15,41]. The prevalence of abnormal glucose homeostasis would 346 
be expected to be lower if all ages or more lean cats had been included. 347 
 348 
3.3. Repeatability for 2-h blood glucose concentrations 349 
Based on our results, there is a 95% expectation that two measurements would differ within 350 
cats by less than 3.8 mmol/L but by as much as 7.2 mmol/L.  Caution is necessary when 351 
interpreting a single test result in client-owned cats because compared to acclimatized cats, 352 
non-acclimatized cats have a longer glucose half-life, attributed to stress [42]. Struggling 10 353 
min prior to blood sampling is reported to increase blood glucose by as much as 10 mmol/L 354 
in cats [24]. We recommend retesting cats with glucose concentrations above the cutpoints, 355 
based on the variability of glucose tolerance test results in humans [43-45] and cats [42], 356 
although owner compliance may limit retesting for client-owned cats.   357 
  358 
3.4. Effect of breed on fasting and 2-h blood glucose concentrations and dose 359 
Neither fasting nor 2-h blood glucose concentrations were higher in Burmese compared to 360 
non-Burmese cats. Despite this, Burmese are 3 to 4 times more likely to develop diabetes 361 
than non-Burmese cats [46]. Because Burmese had significantly higher 2-h blood glucose 362 
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concentrations at the higher dose rate, it could suggest relative intolerance to glucose at 363 
higher doses and this warrants further investigation.  364 
 365 
3.5. Protocol standardization  366 
The glucose dose rate used for a glucose tolerance test depend on the measurements of 367 
interest. In cats, 1 g/kg is more sensitive than 0.5 g/kg for determining abnormalities in 368 
insulin secretory patterns and maximum insulin secretory capacity [15].  However, a lower 369 
glucose dose rate (i.e. 0.5 g/kg) is used when investigating insulin action [14,39].   Our study 370 
used a glucose dose rate of 0.5 g/kg. The higher dose of 1 g/kg was observed to cause nausea 371 
and distress in some cats (personal observations Reeve-Johnson and Gottlieb) and the lower 372 
dose rate (and therefore volume of injection) was considered more user-friendly for 373 
practitioners. However, at 1 g/kg, the significantly higher 2-h glucose concentrations in 374 
Burmese compared to non-Burmese cats raises the question whether a higher glucose dose 375 
can better differentiate cats with impaired glucose tolerance. 376 
Our aim was to establish reference intervals for use in veterinary practice. Our protocol 377 
decreases technical and laboratory variability reported to affect measured blood glucose 378 
concentrations [15]. The same type of portable glucose meter can be used in each veterinary 379 
practice to measure glucose immediately after blood collection, avoiding the variable time 380 
delay in measuring glucose using a variety of serum chemistry analysers in external 381 
laboratories. Postprandial glucose concentrations can be strongly influenced by diet [47] and 382 
thus blood glucose should be measured in fasted cats.  This requires a 14-h fast if less than 383 
50% of the daily energy requirement is consumed, and a 24-h fast after 100% of the daily 384 
energy requirement is consumed [48]. In our study, cats were fasted for 18-24 h and 385 
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hospitalized overnight to avoid owner non-compliance and to minimize confounding of blood 386 
glucose measurement by stress. 387 
 388 
3.6. Associations of 2-min and 2-h glucose concentrations and adjustment for obesity 389 
Adjustment for the spurious effects of obesity on glucose measurements following glucose 390 
dosing based on body weight was further evaluated in this study. While the associations 391 
between 2-min and 2-h glucose concentrations were not significant in the present study 392 
compared to our previous study (Reeve-Johnson et al, unpublished data), the calculated 393 
values for adjustment were very similar to those previously reported (0.05 versus 0.09 394 
mmol/L per unit of body condition above 5; P = 0.282 versus P = 0.006 respectively). Hence, 395 
any cat with a BCS ≥ 6 which is persistently just above the cutpoint at 2 h should have the 396 
observed glucose concentration adjusted downward by 0.1 mmol/L per unit of BCS above 5. 397 
The 2-min blood sample following the glucose injection was difficult to obtain with accurate 398 
timing using a lancing device on the ear using one veterinarian and one handler. Adjusting on 399 
BCS is more precise (Reeve-Johnson et al, unpublished data), and it is therefore 400 
recommended.  401 
4. Conclusions 402 
We have established the methodology and cutpoints for fasting glucose and glucose tolerance 403 
in a simplified intravenous glucose tolerance test for identifying prediabetic cats in clinical 404 
practice with lean or obese body condition. We recommend 6.5 mmol/L  for the cutpoint 405 
between normal and impaired fasting glucose, and 9.8 mmol/L for the 2-h glucose cutpoint 406 
between normal and impaired glucose tolerance when using a glucose dose of 0.5g/kg with 407 
blood glucose measured from ear or pad samples using a portable glucose meter calibrated 408 
for feline blood and performed after an overnight fast and hospitalization. Impaired fasting 409 
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glucose and glucose intolerance should be confirmed by repeat measurements, to minimize 410 
the probability of incorrectly diagnosing a cat with stress hyperglycemia as prediabetic. 411 
Using the criteria established, 20 % of obese cats 8 yrs of age or older are glucose intolerant. 412 
Prospective studies are required to determine the relative risk of diabetes in cats with glucose 413 
concentrations above these cutpoints.  It is recommended that measured 2-h glucose 414 
concentration be adjusted downward by 0.1 mmol/L for every BCS above 5, and tests be 415 
repeated to confirm abnormal glucose tolerance. 416 
 417 
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 561 
Table 1: Descriptive statistics and upper limits of 95 % reference intervals (90 % confidence 562 
intervals) in mmol/L after fasting, and 2 min and 2 h after a glucose infusion of 0.5 g/kg 563 
bodyweight iv for all cats (n = 78) and various sub-groups; BCS  was assessed using a 9 point 564 
scale. 565 
Sub-group of cats Variables  
Fasting blood 
glucose 
(mmol/L) 
2-min blood 
glucose 
(mmol/L) 
2-h blood 
glucose 
(mmol/L) 
BCS 4 or 5 n=         27          27         27 
  Mean 5.1 23.3 5.8 
  Median  4.9 23.4 5.4 
  SEM 0.3   1.2 0.3 
  SD 1.6   6.2 1.5 
  Range        2.4-12.3         12.8-35.9       3.4-9.6 
  95% reference interval upper limit 6.5  36.7 9.8 
  Upper limit 90% CI       6.0-6.7         33.7-38.6         8.5-10.7 
BCS 4 or 5; Burmese 
only n=           6           6           6 
  Mean 4.5 20.7 6.1 
  Median  4.7          23           6 
  SEM 0.4   2.6 0.9 
  SD 1.1   6.4 2.2 
  Range       2.4-5.4         12.8-28.7       3.4-9.6 
  95% reference interval upper limit 1 1 1 
  Upper limit 90% CI 1 1 1 
 BCS 6 or 7 n= 31 31 31 
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  Mean 4.9 24.6 6.4 
  Median  4.4 25.1 5.7 
  SEM 0.3            1 0.5 
  SD           1.5   5.7 2.6 
  Range        3.6-12.4         13.7-35.9 3.4-15.7 
  95% reference interval upper limit 9.1 36.4 13.3 
  Upper limit 90% CI         6.0-10.8         33.3-38.9 10.4-15.6 
 BCS 8 or 9 n= 20 20 20 
  Mean 4.6 25.4 7.9 
  Median  4.6 24.8 7.9 
  SEM 0.2   1.2 0.6 
  SD 0.9   5.5 2.7 
  Range       3.2-6.3         17.3-38.7 3-12.9 
  95% reference interval upper limit 6.6  39.1 14.1 
  Upper limit 90% CI       6.0-7.1          33.8-42.9 12.1-15.8 
All cats (BCS 4-9) n=         78           78 78 
  Mean 4.9   24.4 6.6 
  Median  4.7   24.7 5.8 
  SEM 0.2     0.7 0.3 
  SD 1.4     5.8 2.4 
  Range         2.4-12.4          12.8-38.7 3.0-15.7 
  95% reference interval upper limit 6.3  36.3 12.8 
  Upper limit 90% CI      6.1-6.5          34.4-37.9 11.5-13.9 
    1 Number of cats was insufficient to estimate reference interval 566 
 567 
 568 
 569 
 570 
 571 
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DAE-15-175R2 Highlights 
 
• Aim: to establish methodology and cutpoints for fasting and 2-h blood glucose 
concentrations in healthy client-owned senior cats (> 8 years) using ear/ paw samples 
and a portable glucose meter calibrated for feline blood. 
• Cutpoints for fasting and 2-h glucose concentrations were defined (upper limits of 
95% reference intervals using cats with BCS 4-5 (n = 27)). 
• The upper cutpoint for fasting glucose was 6.5 mmol/L.  
• The cutpoint for 2-h glucose was 9.8 mmol/L.  
 
